scientifyRESEARCH
research funding database

RESEARCH FUNDING

Amyotrophic Lateral Sclerosis Research Program – Pilot Clinical Trial Award (worldwide)

Share this post

Logo of scientifyRESEARCH and Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.
Logo of scientifyRESEARCH + logo of Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.

The Amyotrophic Lateral Sclerosis Research Program – Pilot Clinical Trial Award from the Congressionally Directed Medical Research Programs (CDMRP) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ALS. Projects may range from phase 1 to small-scale phase 2 trials and should aim to de-risk and inform the design of more advanced trials by investigating safety, feasibility, biomarker application, and therapeutic efficacy in relevant patient populations. Clinical trials may be designed to evaluate promising drugs, biologics, or devices with anticipated therapeutic impact that is supported by strong scientific rationale and existing preliminary studies and/or preclinical data. The program is open to researchers in the USA and worldwide.

The award provides up to 2 million USD over 4 years. Indirect costs may be covered.

Funding Opportunity Number: HT942524ALSRPPCTA

Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), May 24, 2024. Application Submission Deadline: 11:59 p.m. ET, July 10, 2024.

Full application due:
July 10, 2024

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time

Be the first to know

Sign-up for Personalized Grant Alerts

Logo3